VRCA Wutah bathi saben saham ing taun iki verrica.com

VRCA (verrica.com) - tandha merek perusahaan

Verrica Pharmaceuticals (VRCA) relies on external contractors for drug manufacturing, making the business dependent on CMO quality. The YoY EPS trend confirms the current state of affairs, where the -30.60 mark reflects the latest data. Sales of YCANTH and new wart therapies are driving growth. The environmental footprint is minimal, as the company is implementing paperless workflows and recyclable applicator packaging.

VRCA: Wutah bathi ing taun lumaku verrica.com 04.07.2022 - 18.11.2026

Rincian analitis lan laporan data perusahaan Verrica (VRCA)

- kuotasi saiki lan rata-rata prakiraan nilai:
Pambiji fundamental:VRCA - Verrica Pharmaceuticals
Produk sing diprodhuksi Verrica Pharmaceuticals Inc

This indicator captures the annual percentage change in net earnings per share. By analyzing the comparable year-over-year growth rate of earnings per share, an investor assesses the efficiency of capital management. The metric is calculated as the difference between current and previous EPS values, revealing the actual increase in profitability. For Verrica Pharmaceuticals (VRCA), this figure reflects the scaling effect of innovative drugs. The high margins of mass-producing dermatological products translate directly into accelerated profit growth.